Anthem Biosciences shares are expected to make strong listing gains on the back of bumper subscription and strong GMP trends.

Is the Anthem Biosciences Ltd profitable? For the year ended 2023, Anthem Biosciences Ltd had posted a profit of Rs 385.19 crore on a total income of Rs 1,056.92 crore. 6. Whic ...

The upcoming week of July 21 to July 25, 2025, is packed with action in the Indian IPO market, with five mainboards and ...

On the last 16 sessions grey market activities, the lowest GMP is Rs 0, while the highest GMP is Rs 157. So, if we go by the ...

Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

Cogent Biosciences, Inc. (NASDAQ:COGT) is one of the 10 Best Small-Cap Stocks to Buy According to Billionaires. On July 7, ...

Waters and BD will merge biosciences and diagnostics in a $17.5B deal via Reverse Morris Trust, creating a life sciences ...

Five acquisitions in 2025—including Cargo and Allakos—have put Concentra Biosciences in the spotlight. Learn what’s behind ...

Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 ...

The BD business will be spun off and merged with a Waters subsidiary. Waters shares were down about 11% in early trading ...

BD has found a new home for its biosciences and diagnostics divisions at the lab equipment maker Waters Corporation, through ...